Liver cell transplantation in children

Clinical Transplantation

Volumn 23, Issue SUPPL.21, 2009, Pages 75-82

  Meyburg, Jochen ^a   Schmidt, Jan ^a   Hoffmann, Georg F ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Acute liver failure; Crigler Najjar syndrome; Hepatocyte transplantation; Inborn errors of metabolism; Metabolic diseases; Urea cycle disorders

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SCATTER FACTOR; STAT PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

BILIRUBIN BLOOD LEVEL; DNA DAMAGE; HEPATIC ENCEPHALOPATHY; HEPATOCYTE TRANSPLANTATION; HUMAN; HYPERAMMONEMIA; INBORN ERROR OF METABOLISM; LIVER FAILURE; LIVER PERFUSION; LIVER SUPPORT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE; UREA CYCLE;

ADOLESCENT; ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; HEPATOCYTES; HUMANS; INFANT; INFANT, NEWBORN; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; METABOLISM, INBORN ERRORS;

EID: 70649110166     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01113.x     Document Type: Review

References (83)

1. Berry MN, Friend DS. High yield preparation of isolated rat liver parenchymal cells: a bichemical and fine structure study. J Cell Biol 1969, 43:506.
2. Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc 1992, 24:3052.
3. Squires RH, Shneider BL, Bucuvalas J. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006, 148:652.
4. Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 2003, 23:203.
5. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006, 43(2 Suppl. 1):S31.
6. Riordan SM, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000, 32(1 Suppl.):63.
7. Sommer BG, Sutherland DE, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc 1979, 11:578.
8. Zhang H, Miescher-Clemens E, Drugas G, Lee SM, Colombani P. Intrahepatic hepatocyte transplantation following subtotal hepatectomy in the recipient: a possible model in the treatment of hepatic enzyme deficiency. J Pediatr Surg 1992, 27:312.
9. Takeshita K, Ishibashi H, Suzuki M, Kodama M. Hepatocellular transplantation for metabolic support in experimental acute ischemic liver failure in rats. Cell Transplant 1993, 2:319.
10. Demetriou AA, Reisner A, Sanchez J, Levenson SM, Moscioni AD, Chowdhury JR. Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats. Hepatology 1988, 8:1006.
11. Yu CH, Chen HL, Chen WT, Ni YH, Lin YL, Chang MH. Portal hemodynamic changes after hepatocyte transplantation in acute hepatic failure. J Biomed Sci 2004, 11:756.
12. Sutherland DE, Numata M, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation in acute liver failure. Surgery 1977, 82:124.
13. Nakamura J, Okamoto T, Schumacher IK. Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. Transplantation 1997, 63:1541.
14. Makowka L, Rotstein LE, Falk RE. Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation. Surgery 1980, 88:244.
15. Gagandeep S, Sokhi R, Slehria S. Hepatocyte transplantation improves survival in mice with liver toxicity induced by hepatic overexpression of Mad1 transcription factor. Mol Ther 2000, 1:358.
16. Baumgartner D, LaPlante O'Neill PM, Sutherland DE, Najarian JS. Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats. Eur Surg Res 1983, 15:129.
17. Aoki T, Jin Z, Nishino N. Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats. Transplantation 2005, 79:783.
18. Krishna Vanaja D, Sivakumar B, Jesudasan RA, Singh L, Janardanasarma MK, Habibullah CM. In vivo identification, survival, and functional efficacy of transplanted hepatocytes in acute liver failure mice model by FISH using Y-chromosome probe. Cell Transplant 1998, 7:267.
19. Chen Y, Kobayashi N, Suzuki S. Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. Transplantation 2005, 79:1378.
20. Sommer BG, Sutherland DE, Simmons RL, Najarian JS. Hepatocellular transplantation for experimental ischemic acute liver failure in dogs. J Surg Res 1980, 29:319.
21. Totsugawa T, Yong C, Rivas Carrillo JD. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination>. J Hepatol 2007, 47:74.
22. Maruyama M, Totsugawa T, Kunieda T. Hepatocyte isolation and transplantation in the pig. Cell Transplant 2003, 12:593.
23. Ambrosino G, Varotto S, Basso S. Hepatocyte transplantation: an experimental study to treat acute liver failure in pigs. Transplant Proc 2001, 33.
24. Ambrosino G, Varotto S, Basso SM. Hepatocyte transplantation in the treatment of acute liver failure: microencapsulated hepatocytes versus hepatocytes attached to an autologous biomatrix. Cell Transplant 2003, 12:43.
25. Arkadopoulos N, Chen SC, Khalili TM. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure. Cell Transplant 1998, 7:357.
26. Habibullah CM, Syed IH, Qamar A, Taher UzZ. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994, 58:951.
27. Strom SC, Fisher RA, Thompson MT. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997, 63:559.
28. Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation 2006, 82:441.
29. Soriano HE, Superina R, Ferry GD. Hepatocyte transplantation (HTX) in children with liver failure. Hepatology 2001, 34:306.
30. Gupta S, Rajvanshi P, Sokhi R. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 1999, 29:509.
31. Pascher A, Sauer IM, Hammer C, Gerlach JC, Neuhaus P. Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation 2002, 9:309.
32. Sgroi A, Serre-Beinier V, Morel P, Buehler L. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation 2009, 87:457.
33. Demetriou AA, Brown RS, Busuttil RW. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004, 239:660.
34. Saliba F. The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Crit Care 2006, 10:118.
35. Rifai K, Manns MP. Review article: clinical experience with Prometheus. Ther Apher Dial 2006, 10:132.
36. Krisper P, Haditsch B, Stauber R. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005, 43:451.
37. Evenepoel P, Laleman W, Wilmer A. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 2006, 30:276.
38. Auth MK, Kim HS, Beste M. Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 2005, 40:54.
39. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Mullhaupt B, Renner EL. Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 2007, 27:475.
40. Faybik P, Bacher A, Kozek-Langenecker SA. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care 2006, 10:R24.
41. Hughes RD, Mitry RR, Dhawan A. Hepatocyte transplantation for metabolic liver disease: UK experience. J R Soc Med 2005, 98:341.
42. Nagata H, Ito M, Shirota C, Edge A, McCowan TC, Fox IJ. Route of hepatocyte delivery affects hepatocyte engraftment in the spleen. Transplantation 2003, 76:732.
43. Guha C, Parashar B, Deb NJ. Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 2002, 36:354.
44. Ilan Y, Roy Chowdhury N, Prakash R. Massive repopulation of rat liver by transplantation of hepatocytes into specific lobes of the liver and ligation of portal vein branches to other lobes. Transplantation 1997, 64:8.
45. Yamaguchi Y, Hamaguchi H, Yamada S. Recombinant human hepatocyte growth factor facilitates biliary transport after hepatocyte transplantation in Eisai hyperbilirubinemic rats. Dig Dis Sci 1997, 42:522.
46. Takahashi M, Deb NJ, Kawashita Y. A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis. Gene Ther 2003, 10:304.
47. Irani AN, Malhi H, Slehria S. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease. Mol Ther 2001, 3:302.
48. Malhi H, Annamaneni P, Slehria S. Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology 2002, 36:112.
49. Malhi H, Gorla GR, Irani AN, Annamaneni P, Gupta S. Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation. Proc Natl Acad Sci USA 2002, 99:13114.
50. Attaran M, Schneider A, Grote C. Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits. J Hepatol 2004, 41:837.
51. Eguchi S, Rozga J, Lebow LT. Treatment of hypercholesterolemia in the Watanabe rabbit using allogeneic hepatocellular transplantation under a regeneration stimulus. Transplantation 1996, 62:588.
52. Grompe M. Therapeutic liver repopulation for the treatment of metabolic liver diseases. Hum Cell 1999, 12:171.
53. Overturf K, al Dhalimy M, Tanguay R. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996, 12:266.
54. Hamman K, Clark H, Montini E. Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria. Mol Ther 2005, 12:337.
55. De Vree JM, Ottenhoff R, Bosma PJ, Smith AJ, Aten J, Oude Elferink RP. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 2000, 119:1720.
56. Michel JL, Rabier D, Rambaud C. Intrasplenic transplantation of hepatocytes in spf-ash mice with congenital ornithine transcarbamylase deficiency. Chirurgie 1993, 119:666.
57. Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency. Hepatology 2004, 39:1048.
58. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999, 19:39.
59. Vroemen JP, Buurman WA, Heirwegh KP, van der Linden CJ, Kootstra G. Hepatocyte transplantation for enzyme deficiency disease in congenic rats. Transplantation 1986, 42:130.
60. Matas AJ, Sutherland DE, Steffes MW. Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science 1976, 192:892.
61. Wilson JM, Chowdhury NR, Grossman M. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci U S A 1990, 87:8437.
62. Gunsalus JR, Brady DA, Coulter SM, Gray BM, Edge AS. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nat Med 1997, 3:48.
63. Wiederkehr JC, Kondos GT, Pollak R. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state A study in the Watanabe rabbit. Transplantation 1990, 50:466.
64. Fox IJ, Chowdhury JR, Kaufman SS. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998, 338:1422.
65. Ambrosino G, Varotto S, Strom SC. Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant 2005, 14:151.
66. Stephenne X, Vosters O, Najimi M. Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl 2007, 13:599.
67. Allen KJ, Cheah DM, Wright P. Immunological considerations in liver cell transplantation for Crigler-Najjar syndrome. J Gastroenterol Hepatol 2005, 20(Suppl.):A71.
68. Strom SC, Fisher RA, Rubinstein WS. Transplantation of human hepatocytes. Transplant Proc 1997, 29:2103.
69. Horslen SP, McCowan TC, Goertzen TC. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003, 111:1262.
70. Mitry RR, Dhawan A, Hughes RD. One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation 2004, 77:1614.
71. Stephenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 2006, 130:1317.
72. Stephenne X, Najimi M, Smets F, Reding R, de Goyet JV, Sokal EM. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 2005, 5:2058.
73. Sokal EM, Smets F, Bourgois A. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 2003, 76:735.
74. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 2004, 78:1812.
75. Muraca M, Gerunda G, Neri D. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002, 359:317.
76. Lee KW, Lee JH, Shin SW. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant 2007, 16:629.
77. Meijer AJ, Lamers WH, Chamuleau RA. Nitrogen metabolism and ornithine cycle function. Physiol Rev 1990, 70:701.
78. Lee K, Berthiaume F, Stephanopoulos GN, Yarmush ML. Profiling of dynamic changes in hypermetabolic livers. Biotechnol Bioeng 2003, 83:400.
79. Tygstrup N, Bak S, Krog B, Pietrangelo A, Shafritz DA. Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat. J Hepatol 1995, 22:349.
80. Tygstrup N, Jensen SA, Krog B, Pietrangelo A, Shafritz DA. Expression of messenger RNA for liver functions following 70% and 90% hepatectomy. J Hepatol 1996, 25:72.
81. Stephenne X, Najimi M, Janssen M, Reding R, de Ville de Goyet J, Sokal EM. Liver allograft radiotherapy to treat rejection in children: efficacy in orthotopic liver transplantation and long-term safety. Liver Int 2005, 25:1108.
82. Mashalova EV, Guha C, Roy Chowdhury N. Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells. Hepatology 2007, 45:755.
83. Ng VL, Alonso M, Bezerra JA. Hepatocyte transplantation Advancing biology and treating children. Clin Liver Dis 2000, 4:929.